You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 4, July 22/29, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Pediatrics
 •Congenital Malformations
 •Pediatrics, Other
 •Cardiovascular System
 •World Health
 •Statistics and Research Methods
 •Malaria
 •Drug Therapy
 •Drug Therapy, Other
 •Congenital Heart Defects
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ancillary Care for Public Health Research in Developing Countries

Adnan A. Hyder, MD, MPH, PhD; Maria W. Merritt, PhD

JAMA. 2009;302(4):429-431.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Belsky and Richardson1 defined ancillary care as care needed by research participants but not necessary to ensure scientific validity, prevent study-related harms, or address study-related injuries and introduced a framework for evaluating ancillary care based on 2 questions.2 Does a participant's need for care fall within the scope of the investigator's responsibility for the participant's health, as defined by aspects of health implicitly entrusted to the investigator through the participant's consent to comply with research procedures? If so, what is the strength of the participant's moral claim on the investigator to address that need? The strength of the claim is modulated by attributes of the participant-investigator relationship, such as depth of involvement, degree of participant's vulnerability, and degree of participant's dependence, together with limits on available resources.2 Dickert et al3 questioned the narrow limits of Belsky and Richardson's definition of . . . [Full Text of this Article]

Ancillary Care in Public Health Research Dealing With Groups as the Unit of Interest

Author Affiliations: Department of International Health, Johns Hopkins Bloomberg School of Public Health, and Johns Hopkins Berman Institute of Bioethics, Baltimore, Maryland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Ancillary Care Obligations of Medical Researchers
Neal Dickert and David Wendler
JAMA. 2009;302(4):424-428.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.